ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -91.7% | 108 | -87.1% | 0.00% | -66.7% |
| Q1 2022 | $12,000 | -40.0% | 836 | +14.8% | 0.00% | -25.0% |
| Q4 2021 | $20,000 | -16.7% | 728 | +2.7% | 0.00% | -20.0% |
| Q3 2021 | $24,000 | +4.3% | 709 | +24.6% | 0.01% | 0.0% |
| Q2 2021 | $23,000 | -8.0% | 569 | -7.5% | 0.01% | -16.7% |
| Q1 2021 | $25,000 | +733.3% | 615 | +1266.7% | 0.01% | +500.0% |
| Q4 2020 | $3,000 | +50.0% | 45 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 45 | -4.3% | 0.00% | – |
| Q2 2020 | $2,000 | – | 47 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |